HDR Brachytherapy Combined With Interstitial Hyperthermia 500 kHz in Locally Advanced Cervical Cancer Patients. A Prospective Clinical Trial
Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Female
Cervical Cancer
Female
Cervical Cancer
Trial Information
HDR Brachytherapy Combined With Interstitial Hyperthermia 500 kHz in Locally Advanced Cervical Cancer Patients. A Prospective Clinical Trial
Inclusion Criteria:
- patients with locally advanced cervical cancer FIGO stage II - III
- signed informed consent for participation in the study
Exclusion Criteria:
- patients with FIGO stage I and IV
- patients with poor performance status with contraindications for radical treatments
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
LC
Outcome Description:
When local relapse was suspected, biopsy was obtained.
Outcome Time Frame:
Follow up was scheduled every 3 months. Preliminary results after 3 years.
Safety Issue:
Yes
Principal Investigator
Agnieszka Żółciak-Siwińska, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
M. Sklodowska-Curie Memorial Cancer Centre and Institute, Roentgena 5, 02-781 Warsaw, Poland
Authority:
Poland: Director of Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology in Warsaw Prof Reinfuss.
Study ID:
HTCCU01
NCT ID:
NCT01474356
Start Date:
November 2006
Completion Date:
March 2009
Related Keywords:
- Cervical Cancer
- brachytherapy
- interstitial hyperthermia
- cervical cancer
- side effects
- Locally advanced cervical cancer patients
- Uterine Cervical Neoplasms
- Fever
Name | Location |
|---|
